Join
Live feed
·
INSIDERFilingvia Quantisnow
KemPharm Inc. logo

SEC Form 4: Plooster Matthew R bought $46,148 worth of shares (11,000 units at $4.20)

ByQuantisnow·Wall Street's wire, on your screen.
KMPH· KemPharm Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KMPH (KemPharm Inc.) and more on Quantisnow.